AzTrials
AzTrials

Amyotrophic Lateral Sclerosis (ALS)VITALSNCT07454733

Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

A study testing Video recording and Notes Instruction in people with Amyotrophic Lateral Sclerosis (ALS), run by Trustees of Dartmouth College at 7 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Amyotrophic Lateral Sclerosis (ALS)
What is being tested?
Video recording and Notes Instruction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
800 participants
Where
7 sitesUnited States
Study dates
12 Aug 2026to 1 Oct 2029
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of ALS by either El- Escorial or Gold Coast Criteria
  • ≥18 years of age
  • Plan to attend MDC visits for 12 months
  • Speak English or Spanish
  • Presence of a caregiver (defined as someone who assists with care) who is also participating in the VITALS trial
  • Projected life expectancy of at least 12 months as determined by the site investigator.
Show all 9Show fewer
  • Agree to their identified role as a caregiver of a patient with ALS participating in the VITALS trial;
  • Speak English or Spanish;
  • ≥18 years of age.

Who cannot join

  • Unable or unwilling to provide informed consent or follow study procedures
  • Significant cognitive impairment, clinical dementia, or unstable psychiatric illness (including, but not limited to, psychosis, active suicidal ideation, suicide attempt, or untreated major depression) as determined by the site investigator
  • Current pregnancy based on participant self-report;
  • Unable to access the internet;
  • Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
  • Do not wish to create a patient portal account, if they do not already have one;
Show all 14Show fewer
  • Uncorrected hearing or visual impairment that would impair the ability to view video recordings;
  • Incarcerated.
  • Unable or unwilling to provide consent or follow study procedures;
  • Unable to access the internet;
  • Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
  • Uncorrected hearing or visual impairment;
  • Professional caregiver for the patient;
  • Incarcerated.

Trial locations and contacts

7 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Kelly M Goedert, PhD contact

603-646-6976

kelly.m.goedert@dartmouth.edu

7 sites in 1 country

United States7 sites, 7 recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, 021114

    Suma Babu, MD, 617-726-2000, sbabu@mgh.harvard.edu

    Suma Babu, MD

    Not yet recruiting
  • Penn State Health Milton S. Hersey Medical Center

    Hershey, Pennsylvania, 17033

    Zachary Simmons, MD, 717-531-1377, zsimmons@pennstatehealth.psu.edu

    Zachary Simmons, MD

    Not yet recruiting
  • Mayo Clinic Jacksonville

    Jacksonville, Florida, 32224

    Björn Oskarsson, MD, 904-953-2903, oskarsson.bjorn@mayo.edu

    Björn Oskarsson, MD

    Not yet recruiting
  • Dartmouth-Hitchcock Health

    Lebanon, New Hampshire, 03756

    Mark Garret, MD, 855-644-6387, Mark.A.Garret@hitchcock.org

    Mark Garret, MD

    Recruiting
  • University of Wisconsin Health

    Madison, Wisconsin, 53792

    Collin Kreple, MD, 608-263-5442, kreple@neurology.wisc.edu

    Collin Kreple, MD

    Not yet recruiting
  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213

    Tawfiq Al Lahham, MD, allahhamt2@upmc.edu

    Tawfiq Al Lahham, MD

    Not yet recruiting
  • Mayo Clinic Scottsdale

    Scottsdale, Arizona, 85259

    Stephen Johnson, MD, 480-301-8000, Johnson.Stephen2@mayo.edu

    Stephen Johnson, MD

    Not yet recruiting

Other trials in United States

About this study

Official title: Comparing the Impact of Video Integration to Traditional Amyotrophic Lateral Sclerosis Visit Communication on Patient and Caregiver Quality of Life

Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). In these multidisciplinary clinics, which occur every 3 to 4 months, people with ALS see up to 12 different healthcare providers (e.g., speech therapy, physical therapy, the ALS doctor). These clinics can last from three to five hours, and across these three to five hours people with ALS and their caregivers receive a lot of information that is critical to the care and quality of life for people with ALS. However, this information can be difficult to remember given the large amount of information that is conveyed. The current standard for providing take-home information about the visit is to provide patients with a written after-visit summary and access to their doctor's notes about the visit, typically through the patient portal. This study tests whether providing participants with video recordings of their MDC visits improves their quality of life and the quality of life of their caregivers. The study will enroll 400 pairs of people with ALS and their caregivers from eight different sites in the United States. Half of the participants in the study will receive their after-visit summary notes (the NOTES condition) and the other half of the participants will receive both their summary notes, but will also receive video recordings of their MDC visits that they can watch on their own at home (the VIDEO condition). The study will last for 12 months, with participants receiving NOTES or VIDEO at each of their regularly-scheduled MDCs during the 12 months. The study will test whether caregiver and patient participants in the VIDEO condition experience better quality of life than those in the NOTES condition at 1 month, 6 months, and 12 months from study enrollment. The results of this study will help determine what is the most effective approach to communicating MDC information to people with ALS and their caregivers.

Read the detailed description

BACKGROUND AND SIGNIFICANCE

Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. People with ALS (pwALS) and their caregivers, attend 3 - 5 hour long multidisciplinary clinics (MDC) every 3 months where they meet with up to 12 specialists. The goal of treatment is to maintain pwALS quality of life (QOL). Optimal information from MDCs is necessary for the intensive at-home management which gets more complex as ALS progresses. Yet 40% of recommendations are forgotten by pwALS negatively impacting QOL, while caregivers report information deficits increasing caregiving burden. Patient portal access to MDC notes is standard, and can improve recall and health outcomes, yet concerns exist about their layout, comprehensiveness and challenges for people with low health literacy. An underutilized strategy to share MDC information is video recording. Systematic reviews find recordings improve health outcomes, and the use of video in an ALS context may be particularly helpful given complicated at-home management. The study will determine what is the most effective approach to communicating MDC information to facilitate optimal delivery of care for pwALS and their caregivers

STUDY AIMS

Aim 1. Assess the comparative effectiveness of written MDC visit information provided to pwALS and their caregivers via the patient portal (NOTES) versus NOTES plus visit video recording (VIDEO) on patient and caregiver quality of life.

Aim 2. Determine whether patient and caregiver health literacy and rapid ALS disease progression are modifying factors on the comparative effectiveness of NOTES versus VIDEO on primary outcomes.

Aim 3. Identify system and patient-level factors that impact the implementation and use of multimodal strategies of MDC information exchange by a diverse sample of pwALS, caregivers, clinicians and health system leaders.

Hypothesis (Main Effect): Compared to those receiving NOTES, pwALS randomized to also receive routine VIDEO recordings of their MDC visit will report better QOL via improved care-management (i.e., treatment adherence), self-management ability, satisfaction with communication and reduced healthcare utilization at 12 months; there will be larger relative benefits for pwALS, and caregivers, with low health literacy and rapid disease progression. The investigators also hypothesize that compared to NOTES alone, caregivers in the VIDEO arm will report better QOL, improved preparedness and less burden at 12 months.

STUDY DESCRIPTION

Overall study design

This study is a multisite, two-arm, parallel group, patient-randomized, controlled, comparative effectiveness trial with 12-month follow-up. Adopting a Hybrid Type 1 design, the investigators will also examine implementation barriers and facilitators using interviews guided by the Consolidated Framework for Implementation Research Framework 2.0.

Comparators

Comparator 1 (NOTES): After the initial MDC study staff will provide a 15-minute training to orient participants to the portal and how to access visit notes.

Comparator 2 (VIDEO): All MDC visits will be video-recorded over 12 months, using HealthPAL, an NIH-funded HIPAA-compliant personal health library developed by PI Barr. Participants in the VIDEO arm will receive orientation to the patient portal and HealthPAL.

Following each scheduled MDC, pwALS and caregivers in both groups will receive emails reminding them to watch the visit video recording and/or review their note: 1) within 48 hours of the visit to remind them of the visit discussion and self-management tasks they may have; and 2) 3 days before their next MDC visit to prepare for their next MDC visit.

Study Population

The study recruit 400 patient and caregiver pairs (400 pwALS and their 400 caregivers) from eight MDC sites (∼50 pairs per site): Dartmouth Health (Lebanon, NH), Massachusetts General Hospital (Boston, MA), Mayo Clinics (Scottsdale, AZ, and Jacksonville, FL), Penn State Health (Hershey, PA), University of Pittsburgh Medical Center (Pittsburgh, PA), University of Wisconsin (Madison, WI) and Virginia Commonwealth University (Richmond, VA). The study will include pwALS, age ≥18 years, who plan to attend MDC visits for 12-months, speak English or Spanish, have ≥12 months projected survival, and internet access and their primary caregivers (family member or friend), ≥18 years who attends MDC visits or assist with their care.

Outcomes

Primary outcomes: For people with ALS, the total score on the ALSAQ-40 (a self report survey measure of quality of life for people with ALS) is the primary outcome. For caregivers, the total score on the PROMIS-10 (a self report survey measure of quality of life); Secondary outcomes include exercise adherence, medication adherence, adherence to MDC recommendations, self-management ability, patient satisfaction with communication, caregiver visit engagement, preparedness for caregiving, and caregiver burden. Exploratory outcomes include healthcare utilization.

Timeframe

Twelve-month follow-up for all outcomes.

Being tested
Video recording, Notes Instruction
Keywords
amyotrophic lateral sclerosis (ALS), Open Notes, Open Recordings, video recording, after-visit summaries
Medical subject headings
Amyotrophic Lateral Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video recordingBehavioural

    We will video record participants' multidisciplinary clinic (MDC) visits for 12 months. Participants will access the videos in HealthPAL, an NIH-funded, HIPAA-compliant personal health library developed with older adults and caregivers, available in Spanish and English. Each specialist visited with during the MDC will have a 'chapter' in HealthPAL that can be reviewed online at home by participants. Participants will receive orientation and training on both their patient portal and HealthPAL, including how to review and share their recordings using a take-home manual (an instructions video is also available in HealthPAL).

  • Notes InstructionBehavioural

    Participants will be given instruction on how to view their after-visit summaries and doctors' notes in their patient portal, as well as how to give other trusted family members or friends access to their visit notes.

Study groups in NCT07454733
Study groupRoleWhat they receive
VIDEOExperimentalParticipants in this arm of the study will have their multidisciplinary clinic visits video recorded and they will be able to access those video recordings on their own at home. They will also be able to access their doctor's notes and after visit summaries through their patient portal.
Receives: Behavioral: Video recording; Behavioral: Notes Instruction
NOTESActive comparatorParticipants in this arm of the study will have their standard access to their doctor's notes and after visit summaries through their patient portal. They will also be provided with training on how to access and share access to their patient portal notes.
Receives: Behavioral: Notes Instruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. For Caregiver Participants: the total score on the PROMIS-10 self report survey

    The Patient-Reported Outcomes Measurement Information System-10 (PROMIS-10) is a self-report measure of quality of life. The PROMIS-10 will be administered to caregivers via a secure online survey. We will analyze the total score on the PROMIS-10 as the primary outcome for caregiver participants.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  2. For Patient Participants: The total score on the ALSAQ-40 self report survey.

    The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) is a self-report measure of quality of life for people with ALS. The ALSAQ-40 will be administered via a secure online survey.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

Secondary outcomes (8)
  1. Total Score on the Patient Activation Measure Short Form (PAM-SF)

    The PAM-SF is a self-reported measure of self-management ability. It will be administered to participants with ALS via a secure online survey.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  2. Total Score on the Exercise Adherence Rating Scale (EARS)

    The EARS is a self-report measure of exercise adherence. It will be administered to participants with ALS via a secure online survey.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  3. Total Score on the Adherence to Refills and Medications Scale (ARMS)

    The ARMS is a self-report measure of medication adherence. It will be administered to participants with ALS via a secure online survey.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  4. Total Score on the Adherence to Multidisciplinary Clinic Recommendations

    Using a secure online survey, participants with ALS will indicate which of a list of possible clinic recommendations they received and the extent to which they adhered to those recommendations.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  5. Total Score on the Interpersonal Processes of Care (IPC) Survey

    The IPC is a self-report measure of satisfaction with the communication during a doctor visit. It will be administered via a secure online survey to participants with ALS.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  6. Total Score on the Caregiver Perceptions About Communication with Clinical Team (CAPACITY) Survey

    CAPACITY is a self-report measure of satisfaction with the communication during a doctor visit. It will be administered via a secure online survey to caregivers attending multidisciplinary clinic visits with the patient participants.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  7. Total Score on the Preparedness for Caregiving Scale

    The Preparedness for Caregiving Scale is a self-report measure, completed by the caregiver, of the caregiver's self-perceived readiness to provide care across different domains (e.g., physical, emotional). It will be administered to caregivers via a secure online survey.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

  8. Total Score on the Burden Scale for Family Caregivers - Short Form (BSFC)

    The BSFC is a self-report measure of caregiver burden. It will be administered via a secure online survey to participant caregivers.

    Measured: Administered at enrollment (baseline) and 1 month, 6 months, and 12 months after enrollment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2026
  2. Study start12 Aug 2026
  3. Primary completion1 Sep 2029 (estimated)
  4. Study completion1 Oct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07454733
Sponsor's protocol ID
RD-2024C2-40039
Acronym
VITALS
Status last verified
Oct 2026
First submitted
25 Feb 2026
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified non-video data that will be shared include demographic data (e.g., age, gender, language, race, ethnicity, income); information on use of the patient portal and video recordings; researcher field notes (e.g., if a caregiver is present at a visit, whether the visit was telehealth or in-person); participant-reported survey responses (e.g., assessments measuring cognitive function, health literacy, quality of life, adherence, self-management ability, caregiver burden, caregiver preparedness). We will also share raw video recordings of the participants' multidisciplinary clinic visits. Raw video recordings will not be accompanied by personal identifying information, but they will not be stripped of any visual or auditory features that could potentially identify an individual.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in